CETTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.209
EU - Europa 2.214
AS - Asia 2.160
SA - Sud America 206
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 7.823
Nazione #
US - Stati Uniti d'America 3.133
CN - Cina 1.326
IE - Irlanda 550
SG - Singapore 416
UA - Ucraina 325
RU - Federazione Russa 274
FI - Finlandia 269
DE - Germania 249
HK - Hong Kong 213
BR - Brasile 172
GB - Regno Unito 137
IT - Italia 115
SE - Svezia 102
VN - Vietnam 66
FR - Francia 60
CA - Canada 39
BE - Belgio 36
IN - India 31
MX - Messico 27
TR - Turchia 21
AR - Argentina 18
IR - Iran 18
CZ - Repubblica Ceca 17
JP - Giappone 16
ES - Italia 14
NL - Olanda 14
PL - Polonia 14
ZA - Sudafrica 12
BD - Bangladesh 11
LT - Lituania 9
AT - Austria 7
ID - Indonesia 6
IQ - Iraq 6
RO - Romania 6
CO - Colombia 5
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
JM - Giamaica 4
MA - Marocco 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
CL - Cile 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PK - Pakistan 3
AL - Albania 2
BG - Bulgaria 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
KE - Kenya 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.823
Città #
Dublin 550
Chandler 505
Jacksonville 376
Beijing 317
Dallas 267
Nanjing 255
Ashburn 231
Hong Kong 213
Singapore 208
Ann Arbor 171
Boardman 143
Nanchang 110
Los Angeles 93
Lawrence 82
Princeton 82
Wilmington 81
Medford 80
Shenyang 80
Changsha 79
Helsinki 74
Munich 71
Hebei 65
Jiaxing 63
Hangzhou 60
Shanghai 59
Moscow 55
Woodbridge 55
Tianjin 54
Milan 47
New York 43
Buffalo 37
Brussels 35
Turku 33
Verona 26
Houston 23
Auburn Hills 22
São Paulo 22
Washington 22
Ho Chi Minh City 21
Chicago 20
Brooklyn 18
Frankfurt am Main 17
Orem 17
Santa Clara 17
The Dalles 14
Hanoi 13
Norwalk 13
Redondo Beach 13
Tokyo 13
Chennai 12
London 12
Toronto 12
Ankara 11
Denver 11
Mexico City 11
Montreal 11
Seattle 11
Stockholm 11
Warsaw 11
Dearborn 10
Falkenstein 10
Johannesburg 10
Kunming 10
Atlanta 9
Pavia 9
Ardabil 8
Boston 8
Brno 8
Ningbo 8
Fairfield 7
Olomouc 7
Poplar 7
San Francisco 7
Des Moines 6
Jinan 6
Ottawa 6
Belo Horizonte 5
Columbus 5
Manchester 5
Monmouth Junction 5
Phoenix 5
Rio de Janeiro 5
Tappahannock 5
Zhengzhou 5
Bogotá 4
Elk Grove Village 4
Haiphong 4
Jakarta 4
Kingston 4
Lanzhou 4
Ninh Bình 4
Quận Bảy 4
Riyadh 4
Rome 4
Sacramento 4
Tashkent 4
Aracaju 3
Baoding 3
Bexley 3
Casablanca 3
Totale 5.314
Nome #
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 151
Adesion proteins in CHO cells. 143
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 140
Biodegradable microspheres for prolidase delivery to human cultured fibroblasts 139
Cartilage histogenesis in a murine model of chondrodysplasia 138
Micellar electrokinetic chromatography for analyzing active site specificity of Pseudomonas aeruginosa elastase. 137
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 136
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 130
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 130
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 125
Effects of lactitol compared to polyethylene glicol-3350 on fecal short chain fatty acids and microflora in old patients with idiopathic chronic constipation. 124
Sequencing prolidase from pig kidney using multiple enzymatic digestion and LC-ESI-QTOF 121
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 120
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 120
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 119
Investigation on transcellular delivery of active enzyme relased from PLGA microspheres 117
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 116
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 113
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis 113
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts 112
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 110
Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study 110
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 108
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 107
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 106
Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis. 105
Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients 105
Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency. 104
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 103
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 103
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 103
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 103
Complete resolution of imidodipeptide mixtures in urine of prolidase-deficient patients using micellar electrokinetic chromatography. 103
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 102
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 100
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 100
Intracellular release of a liposome-incapsulated biologically active protein 99
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 98
Enzyme replacement as a new therapy for prolidase deficiency 96
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 96
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 96
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 96
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 95
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 94
The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach 93
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 93
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 93
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity. 92
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis. 92
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 91
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 91
Stability of type I collagen peptide trimers. 90
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 89
High levels of desmosines in urine and plasma of patients with pseudoxanthoma elasticum. 87
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspects. 86
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 86
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 84
Mild, late-onset prolidase deficiency: another Italian case. 81
Therapeutic apheresis exchange in two patients with prolidase deficiency 81
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 79
Type I collagen CNBr peptides: species and behavior in solution 78
Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: in vitro biocompatibility study by using primary human fibroblasts and osteoblasts 78
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 76
Effect of different surfactants on the separation by micellar electrokinetic chromatography of a complex mixture of dipeptides in urine of prolidase-deficient patients. 76
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 75
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 74
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 74
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 73
Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography 71
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 69
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation. 69
Proteoglycan modifications in cultured Osteogenesis Imperfecta skin fibroblasts. 68
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 66
Serum type I and type III procollagen peptide levels in sarcoidosis. 65
Gly85 to Val substitution in proa1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion. 64
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 62
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production 60
Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2 60
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine a1(I) 901 substitution in a type-I collagen gene. 59
Relationship between changes in alveolar surfactant levels and lung defence mechanisms. 57
Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen. 52
Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. 47
Totale 7.867
Categoria #
all - tutte 31.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 66 9 93 13 84 73 15
2021/2022417 7 12 18 8 10 7 11 29 17 12 67 219
2022/20231.445 129 142 13 113 161 123 5 61 622 20 42 14
2023/2024504 72 90 31 48 51 104 26 29 9 18 17 9
2024/20251.331 40 97 46 34 37 63 69 33 360 39 197 316
2025/20261.615 242 190 372 383 384 44 0 0 0 0 0 0
Totale 7.867